Mitochon Pharmaceuticals

259 Radnor Chester Road
Suite 210
Radnor
Pennsylvania
19087
United States

Show jobs for this employer

About Mitochon Pharmaceuticals

Mitochon was founded in 2014 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to neurodegeneration, neuromuscular, and developmental diseases. Mitochon’s lead programs, MP101 and MP201, specifically harnesses the power of the mitochondria to provide broad neural protection. These compounds elicit mild increases in energy expenditure that result in strengthening cellular survival – similar to the positive effects seen with fasting and exercise. These compounds also induce an important neurotrophin, Brain Derived Neurotrophic Factor (BDNF), involved in cognition and neural growth.

YEAR FOUNDED:
2014

LEADERSHIP:
Founder and CEO: Robert Alonso
Founder & CSO: John G. Geisler, PhD
Acting CMO: Robert Elfont MD

CAREER:
Please click here for Mitochon Pharma's job opportunities.

PIPELINE:
Please click here for Mitochon Pharma's pipeline.

3 articles with Mitochon Pharmaceuticals